Literature DB >> 23157487

Premenstrual syndrome and dysphoric disorder as risk factors for postpartum depression.

Sara M Sylvén1, Lisa Ekselius, Inger Sundström-Poromaa, Alkistis Skalkidou.   

Abstract

OBJECTIVE: To investigate a possible association between postpartum depression and premenstrual symptoms.
DESIGN: Population-based cohort.
SETTING: University Hospital, Sweden. POPULATION: During one year, May 2006 to June 2007, all delivering women in the hospital were asked to participate.
METHODS: The participating women answered three questionnaires, at five days, six weeks and six months postpartum, containing the Edinburgh Postnatal Depression Scale (EPDS) and questions assessing previous premenstrual symptoms, medical history and life style. MAIN OUTCOME MEASURES: The woman's self-reported depressive case/control status, women with 12 or more points on the EPDS being considered as cases.
RESULTS: Among the 2318 participating women, 7.1% had a history of premenstrual syndrome and 2.9% a history of premenstrual dysphoric disorder. Previous premenstrual syndrome/premenstrual dysphoric disorder was associated with self-reported postpartum depression at five days, six weeks and six months postpartum. After stratification for parity, the associations remained significant solely among multiparas.
CONCLUSIONS: There appears to be an association between a history of premenstrual symptoms and development of self-reported postpartum depression. Parity was identified as effect modifier. This finding is clinically important for health care professionals working in maternity care.
© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica © 2012 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2012        PMID: 23157487     DOI: 10.1111/aogs.12041

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

Review 1.  Association between premenstrual dysphoric disorder and perinatal depression: a systematic review.

Authors:  Daniela Pereira; Ana Rita Pessoa; Nuno Madeira; António Macedo; Ana Telma Pereira
Journal:  Arch Womens Ment Health       Date:  2021-08-26       Impact factor: 3.633

2.  Relationship of premenstrual syndrome and premenstrual dysphoric disorder with major depression: relevance to clinical practice.

Authors:  Susanta Kumar Padhy; Sidharth Sarkar; Prakash B Beherre; Rajesh Rathi; Mahima Panigrahi; Pradeep Sriram Patil
Journal:  Indian J Psychol Med       Date:  2015 Apr-Jun

3.  Is catechol-o-methyltransferase gene polymorphism a risk factor in the development of premenstrual syndrome?

Authors:  Esma Ozturk Deveci; Adnan Incebiyik; Salih Selek; Aysun Camuzcuoglu; Nese Gul Hilali; Hakan Camuzcuoglu; Mehmet Emin Erdal; Mehmet Vural
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

4.  Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis.

Authors:  Mingzhou Gao; Dongmei Gao; Hui Sun; Xunshu Cheng; Li An; Mingqi Qiao
Journal:  Front Public Health       Date:  2021-04-21

5.  Premenstrual symptoms across the lifespan in an international sample: data from a mobile application.

Authors:  Liisa Hantsoo; Shivani Rangaswamy; Kristin Voegtline; Rodion Salimgaraev; Liudmila Zhaunova; Jennifer L Payne
Journal:  Arch Womens Ment Health       Date:  2022-08-26       Impact factor: 4.405

6.  Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries.

Authors:  Jennifer Hahn-Holbrook; Taylor Cornwell-Hinrichs; Itzel Anaya
Journal:  Front Psychiatry       Date:  2018-02-01       Impact factor: 4.157

7.  Development of an Assessment Tool of Menstrual-Cycle-Related Signs and Symptoms Based on Thai Traditional Medicine Principles for Evaluation of Women's Health.

Authors:  Kodchanipha Sutthibut; Arunporn Itharat; Phechnoy Singchungchai; Preecha Wanichsetakul; Weerachai Pipatrattanaseree; Buncha Ooraikul; Neal M Davies
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.